[The Street] Retrophin Assailed for 'Exorbitant' Price Hike

NEW YORK (TheStreet) — Runaway drug pricing has become a recent hot topic, witnessed best by the media and political bashing of Gilead Sciences (GILD_) for the $1,000-per-day cost of its hepatitis C pill Sovaldi. It didn’t take me long, however, to come to terms with the rationale for the outsized sticker prices attached to some drugs, particularly after reading the story of Vertex Pharmaceuticals (VRTX_) and its cystic fibrosis drugs in Barry Werth’s book “The Antidote.”

Read More